Telix Pharmaceuticals Limited Revenue From Contracts With Customers
Telix Pharmaceuticals Limited (TLPPF) reported Revenue From Contracts With Customers of $803.79 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Income Statement › Other Income
ifrs-full:RevenueFromContractsWithCustomers · last filed 2026-02-20
AUD
| Period end | Revenue From Contracts With Customers 12 month |
|---|---|
| 2024-12-31 | 783.21M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 502.55M AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | 160.10M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Revenue From Contracts With Customers 12 month |
|---|---|
| 2025-12-31 | $803.79M 20-F · filed 2026-02-20 |
| 2024-12-31 | $516.55M 20-F · filed 2026-02-20 |
| 2023-12-31 | $332.98M 20-F · filed 2026-02-20 |